Furthermore, our in vivo study demonstrated that administering 20 mg/kg body weight of EDM effectively suppresses EBV/LMP1-mediated endometriosis development in a mouse model, indicating an intriguing therapeutic potential for EDM in clinical treatment for endometriosis (Shyu et al., 2006; Shi et al., 2016). This evidence concerns the gene PDLIM7 and endometriosis.